| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |
|
|
|
||||||||||
|
||||||||||||
The British Journal of Psychiatry 133: 28-33 (1978)
© 1978 The Royal College of Psychiatrists
A Coppen, K Ghose, S Montgomery, VA Rama Rao, J Bailey and A Jorgensen
Thirty-two patients who had responded to amitriptyline (150 mg daily) when suffering from a depressive illness were allocated either to receive placebo or to remain on the same medication for one year. Plasma concentrations of the drug were regularly estimated. There was no correlation between plasma concentration and subsequent residual affective morbidity. In spite of considerable encouragement, three of the patients did not take the prescribed amitriptyline and they all relapsed. Five out of sixteen patients who received placebo relapsed. None of the patients who continued to take amitriptyline relapsed. It is emphasized that the patients studied were selected, inasmuch as they were apparent responders to amitriptyline. It is concluded that this group of patients should continue to be treated with antidepressant medication for eight months after apparent recovery, and care should be taken to ensure the patients' compliance.
This article has been cited by other articles:
|
|
 |
|
  R. M. A. HIRSCHFELD Clinical importance of long-term antidepressant treatment The British Journal of Psychiatry, September 1, 2001; 179 (42): s4 - s8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E S Paykel Continuation and maintenance therapy in depression Br. Med. Bull., March 1, 2001; 57(1): 145 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bauer, T. Bschor, D. Kunz, A. Berghöfer, A. Ströhle, and B. Müller-Oerlinghausen Double-Blind, Placebo-Controlled Trial of the Use of Lithium to Augment Antidepressant Medication in Continuation Treatment of Unipolar Major Depression Am J Psychiatry, September 1, 2000; 157(9): 1429 - 1435. [Abstract] [Full Text]
|
|
|
|
|
|
F. W. Reimherr, J. D. Amsterdam, F. M. Quitkin, J. F. Rosenbaum, M. Fava, J. Zajecka, C. M. Beasley Jr., D. Michelson, P. Roback, and K. Sundell Optimal Length of Continuation Therapy in Depression: A Prospective Assessment During Long-Term Fluoxetine Treatment Am J Psychiatry, September 1, 1998; 155(9): 1247 - 1253. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Lane The long-term management of depression J Psychopharmacol, January 1, 1995; 9(2_suppl): 191 - 198. [Abstract] [PDF]
|
|
|
|
|
|
K. Malcolm, J. Dean, P. Rowlands, and M. Peet Antidepressant drug treatment in relation to the use of ECT J Psychopharmacol, January 1, 1991; 5(3): 255 - 258. [Abstract] [PDF]
|
|
|
|
|
|
S. A. Montgomery Prophylaxis in recurrent unipolar depression: a new indication for treatment studies J Psychopharmacol, January 1, 1989; 3(2): 47 - 53. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |
